Mirror syndrome (that is fetal hydrops with subsequent edema in the pregnant woman) is a rare condition. Early diagnosis is warranted, as maternal and fetal morbidity and mortality is increased if not diagnosed and treated properly. In most cases, the underlying cause remains unclear. We report a woman who has had two pregnancies complicated by mirror syndrome. Congenital disorder of glycosylation type Ia (CDG-Ia) was identified as the underlying fetal disease in both cases.
Introduction
Fetal hydrops first was described in the setting of rhesus incompatibility, but in recent years, many nonimmune causes have been identified including congenital heart disease, fetal arrhythmias, congenital anomalies, chromosomal abnormalities, viral infections, anemia, congenital hydrothorax and metabolic disorders. 1 The term mirror syndrome, which was first described in 1892 by John Ballantyne, describes the clinical entity of maternal edema related to fetal hydrops. The underlying pathophysiology of this 'mirroring' of the fetal hydrops in the mother still remains unclear. Mirror syndrome is rarely encountered in clinical practice and may be underdiagnosed. 2 Today, it is considered to be a subset of preeclampsia and recent case reports on placenta-derived soluble fms-like thyrosine kinase 1 in pregnant women with preeclampsia and mirror syndrome show elevated levels in both groups, suggesting similar pathophysiologic origin. 3, 4 Clinical signs of mirror syndrome include massive edema, oliguria and hemodilution. 5 If left untreated, mirror syndrome may progress into severe preeclampsia. 6 The congenital disorders of glycosylation represent a heterogeneous group of autosomal recessive inherited glycosylation disorders with type Ia (McKusick no. 212065) being the most common. About 500 cases are described worldwide but the real incidence may be higher due to unawareness of this metabolic disorder. The corresponding gene is found on chromosome 16p13. CDG-Ia is the result of a deficiency of phosphomannomutase-2 (PMM2), a cytosolic enzyme that converts mannose-6-phosphate into mannose-1-phosphate. This results in a hypoglycosylation of various glycoproteins and other glycoconjugates. 7 Typical clinical signs include inverted nipples, unusual fat pads and internal strabismus. On the basis of clinical features, there are two courses of the disease: patients with the neurological form suffer mainly from psychomotor retardation, internal strabismus and axial hypotonia. 8 Patients with the multivisceral form in addition may present with fetal hydrops, hypertrophic cardiomyopathy, cerebellar hypoplasia, thrombocytopenia and hyperinsulinemic hypoglycemia. Screening for CDG-Ia is made by isoelectric focusing of transferrin. After obtaining an abnormal result, measuring the activity of PMM2 in fibroblasts or leukocytes is the next step before molecular analysis.
We report the clinical course and further features of two siblings with proven CDG-Ia with both pregnancies being complicated by fetal hydrops with mirror syndrome.
Case
The first pregnancy of the 34-year-old woman was complicated by maternal edema and rapid increase of body weight at 31 weeks of gestation (Table 1) . On admission, ultrasound revealed fetal hydrops with ascites. Her blood pressure was normal, there was mild oliguria, no proteinuria and hematocrit was 34%. The diagnostic workup excluded rhesus incompatibility, viral and autoimmune diseases. After 36 weeks of gestation, the male baby was born via cesarean section.
The second pregnancy in 2002 was uneventful and the mother delivered a healthy girl at term.
The third pregnancy again took the same course as the first one. The mother noted edema and increase of body weight (Table 1) . On admission, clinical signs and laboratory results were similar to the first pregnancy. Ultrasound revealed fetal hydrops with ascites and pericardial effusion, and the girl was born after 35 weeks of gestation via cesarean section.
Postnatally, both affected children presented with marked hydrops, hypoglycemia and thrombocytopenia. Known maternal and neonatal disorders causing thrombocytopenia in the neonate could be excluded. Both children developed progressive hypertrophic cardiomyopathy with restriction and died from acute cardiac failure at 3 and 8 weeks, respectively. The first baby died without establishing any diagnosis. However, as the hydrops in the second affected baby had disappeared, we observed the typical signs of CDG-Ia: unusual fat pads around the buttocks, neck and arms, inverted nipples ( Figure 1 ) and internal strabismus. Screening for CDG-Ia using isoelectric focusing of transferrin was abnormal. The activity of PMM2 in leukocytes was nearly absent. When searching for the responsible mutation, a compound heterozygosity was found with the maternal allele showing a G insertion between nucleotides 161-162 in exon 2, leading to a frameshift. Paternal allele showed 385G>T (V129L) in exon 5. After establishing the diagnosis of CDG-Ia in the second affected baby, a mutation analysis from stored embedded tissue of the first baby was performed, showing an identical genotype.
After delivery of the two affected neonates, the mother's edema quickly disappeared and she did well thereafter. The mother again became pregnant in 2005 and underwent prenatal testing. Mutation analysis of the fetus showed only a carrier for the maternal allele. Pregnancy was uneventful and the mother delivered a healthy boy at term.
Comment
In our case, CDG-Ia was associated with fetal hydrops and the mother subsequently developed mirror syndrome. CDG-Ia has been described as a possible cause of fetal hydrops 7 but not in mirror syndrome. This rare condition has been described in 20 cases worldwide 6 and needs early diagnosis and treatment because of increased risk for the mother and the fetus. Treatment of the fetal hydrops whenever possible is essential. Midgley et al. 9 reported a case of fetal tachycardia treated with flecainide. When the fetal hydrops resolved, the mirror syndrome improved. Pirhonen and Hartgill 10 reported on a twin pregnancy with one hydropic fetus A recent analysis of 598 cases with fetal hydrops showed that in 26.3% the underlying reason could not be found, 1 and only 0.8% were detected with inborn errors of metabolism. The incidence of CDG-Ia is 1:20 000, and probably half of them are diagnosed. 11 So, when investigating a hydropic newborn, the differential diagnosis always should include congenital disorders of glycosylation, especially when additional dysmorphic features (inverted nipples) or other symptoms (thrombocytopenia, hypoglycemia) are seen. Although isoelectric focusing of transferrin is thought to be unreliable in the first days of life, the two patients from van de Kamp and co-workers showed an abnormal pattern on the second day of life, suggesting that the more severe presentations of CDG-Ia with fetal hydrops can be diagnosed in the first days of life. In case the activity of the PMM2 is decreased too, DNA analysis should be undertaken to assess future pregnancy risk. In our case, the mutation was identified in both parents and mutation analysis could be performed utilizing fetal cells in the fourth pregnancy.
